Stocks and Investing
Stocks and Investing
Mon, December 5, 2022
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Sun, December 4, 2022
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Fri, December 2, 2022
Thomas Shrader Initiated (BHVN) at Strong Buy and Held Target at $24 on, Dec 2nd, 2022
Thomas Shrader of BTIG, Initiated "Biohaven Ltd." (BHVN) at Strong Buy and Held Target at $24 on, Dec 2nd, 2022.
Thomas has made no other calls on BHVN in the last 4 months.
There are 2 other peers that have a rating on BHVN. Out of the 2 peers that are also analyzing BHVN, 1 agrees with Thomas's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Laura Chico of "Wedbush" Downgraded from Buy to Hold and Held Target at $149 on, Monday, August 8th, 2022
This is the rating of the analyst that currently disagrees with Thomas
- Christopher Raymond of "Piper Sandler" Maintained at Buy with Decreased Target to $21 on, Wednesday, October 26th, 2022
Contributing Sources